Jaume Puig-Junoy

ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2017-2023
Publications (10 Years): 13

Top Venues

Health economics review

Applied health economics and health policy

Expert review of gastroenterology & hepatology

Health economics

Universitat Pompeu Fabra

Universitat Autònoma de Barcelona (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Universitat Pompeu Fabra May 01 1992

Spain

Senior professor :: Barcelona School of Management

Education History

Universitat Autònoma de Barcelona

Spain

PHD :: Economics

Publications

Toni Mora, Jaume Puig-Junoy, Rowena Jacobs, Jordi Cid
Differential costs for the non-adult ADHD population in Catalonia. Health economics review 13 (1) (2023)
Toni Mora, Jaume Puig-Junoy, Rowena Jacobs, Jordi Cid
Differential costs for the non-adult ADHD population in Catalonia. Health economics review 13 (1) (2023)
Toni Mora, Jaume Puig-Junoy, Rowena Jacobs, Jordi Cid
Differential costs for the non-adult ADHD population in Catalonia. Health economics review 13 (1) (2023)
Toni Mora, Jaume Puig-Junoy, Rowena Jacobs, Jordi Cid
Differential costs for the non-adult ADHD population in Catalonia. Health economics review 13 (1) (2023)
Toni Mora, Jaume Puig-Junoy, Rowena Jacobs, Jordi Cid
Differential costs for the non-adult ADHD population in Catalonia. Health economics review 13 (1) (2023)
Hani Fares, Jaume Puig-Junoy
Inequity and benefit incidence analysis in healthcare use among Syrian refugees in Egypt. Conflict and health 15 (1) (2021)
Jaume Puig-Junoy, Jaime Pinilla Dominguez
Free prescriptions for low-income pensioners? The cost of returning to free-of-charge drugs in the Spanish National Health Service. Health economics 29 (12) (2020)
Lluc Puig-Codina, Jaime Pinilla Dominguez, Jaume Puig-Junoy
The impact of taxing sugar-sweetened beverages on cola purchasing in Catalonia: an approach to causal inference with time series cross-sectional data. The European journal of health economics : HEPAC : health economics in prevention and care 22 (1) (2020)
Carlos Campillo-Artero, Jaume Puig-Junoy, Anthony J Culyer
Authors' Reply to Angelis and Kanavos: "Does MCDA Trump CEA?" Applied health economics and health policy 17 (1) (2019)
Pilar García-Gómez, Toni Mora, Jaume Puig-Junoy
Does €1 Per Prescription Make a Difference? Impact of a Capped Low-Intensity Pharmaceutical Co-Payment. Applied health economics and health policy 16 (3) (2019)
Carlos Campillo-Artero, Jaume Puig-Junoy, Anthony J Culyer
Does MCDA Trump CEA? Applied health economics and health policy 16 (2) (2019)
Jaume Puig-Junoy, Natàlia Pascual-Argente, Lluc Puig-Codina, Laura Planellas, Míriam Solozabal
Cost-utility analysis of second-generation direct-acting antivirals for hepatitis C: a systematic review. Expert review of gastroenterology & hepatology 12 (12) (2018)
Natàlia Pascual-Argente, Jaume Puig-Junoy, Anna Llagostera-Punzano
Non-healthcare costs of hepatitis C: a systematic review. Expert review of gastroenterology & hepatology 12 (1) (2017)

Jaume Puig-Junoy.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Jaume Puig-Junoy